List of Excipients in API donislecel
✉ Email this page to a colleague
Detailed excipient profiles for donislecel
Excipient focus: 2'-DEOXYADENOSINE
donislecel drug variants containing 2'-DEOXYADENOSINE
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing 2'-DEOXYADENOSINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: 2'-DEOXYGUANOSINE
donislecel drug variants containing 2'-DEOXYGUANOSINE
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing 2'-DEOXYGUANOSINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: 5-METHYLDEOXYCYTIDINE
donislecel drug variants containing 5-METHYLDEOXYCYTIDINE
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing 5-METHYLDEOXYCYTIDINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: ALANINE
donislecel drug variants containing ALANINE
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing ALANINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: ALANYL GLUTAMINE
donislecel drug variants containing ALANYL GLUTAMINE
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing ALANYL GLUTAMINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: ALBUMIN HUMAN
donislecel drug variants containing ALBUMIN HUMAN
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing ALBUMIN HUMAN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: AMINOBENZOIC ACID
donislecel drug variants containing AMINOBENZOIC ACID
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing AMINOBENZOIC ACID
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS DEXTROSE
donislecel drug variants containing ANHYDROUS DEXTROSE
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing ANHYDROUS DEXTROSE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: ARGININE HYDROCHLORIDE
donislecel drug variants containing ARGININE HYDROCHLORIDE
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing ARGININE HYDROCHLORIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: ASCORBIC ACID
donislecel drug variants containing ASCORBIC ACID
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing ASCORBIC ACID
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: ASPARTIC ACID
donislecel drug variants containing ASPARTIC ACID
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing ASPARTIC ACID
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: BIOTIN
donislecel drug variants containing BIOTIN
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing BIOTIN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CALCIUM CHLORIDE ANHYDROUS
donislecel drug variants containing CALCIUM CHLORIDE ANHYDROUS
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing CALCIUM CHLORIDE ANHYDROUS
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CALCIUM PANTOTHENATE
donislecel drug variants containing CALCIUM PANTOTHENATE
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing CALCIUM PANTOTHENATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CHOLESTEROL
donislecel drug variants containing CHOLESTEROL
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing CHOLESTEROL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CHOLINE CHLORIDE
donislecel drug variants containing CHOLINE CHLORIDE
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing CHOLINE CHLORIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: COCARBOXYLASE
donislecel drug variants containing COCARBOXYLASE
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing COCARBOXYLASE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: COENZYME A TRILITHIUM DIHYDRATE
donislecel drug variants containing COENZYME A TRILITHIUM DIHYDRATE
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing COENZYME A TRILITHIUM DIHYDRATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CYSTEINE HYDROCHLORIDE
donislecel drug variants containing CYSTEINE HYDROCHLORIDE
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing CYSTEINE HYDROCHLORIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CYSTINE DIHYDROCHLORIDE
donislecel drug variants containing CYSTINE DIHYDROCHLORIDE
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing CYSTINE DIHYDROCHLORIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: DEOXYCYTIDINE HYDROCHLORIDE
donislecel drug variants containing DEOXYCYTIDINE HYDROCHLORIDE
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing DEOXYCYTIDINE HYDROCHLORIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: DOXRIBTIMINE
donislecel drug variants containing DOXRIBTIMINE
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing DOXRIBTIMINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FLAVIN ADENINE DINUCLEOTIDE DISODIUM
donislecel drug variants containing FLAVIN ADENINE DINUCLEOTIDE DISODIUM
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing FLAVIN ADENINE DINUCLEOTIDE DISODIUM
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FOLIC ACID
donislecel drug variants containing FOLIC ACID
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing FOLIC ACID
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: GLUTAMIC ACID
donislecel drug variants containing GLUTAMIC ACID
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing GLUTAMIC ACID
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: GLUTATHIONE
donislecel drug variants containing GLUTATHIONE
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing GLUTATHIONE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: GLYCINE
donislecel drug variants containing GLYCINE
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing GLYCINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: HISTIDINE MONOHYDROCHLORIDE MONOHYDRATE
donislecel drug variants containing HISTIDINE MONOHYDROCHLORIDE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing HISTIDINE MONOHYDROCHLORIDE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: HYDROXYETHYLPIPERAZINE ETHANE SULFONIC ACID
donislecel drug variants containing HYDROXYETHYLPIPERAZINE ETHANE SULFONIC ACID
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing HYDROXYETHYLPIPERAZINE ETHANE SULFONIC ACID
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROLINE
donislecel drug variants containing HYDROXYPROLINE
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing HYDROXYPROLINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: INOSITOL
donislecel drug variants containing INOSITOL
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing INOSITOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: ISOLEUCINE
donislecel drug variants containing ISOLEUCINE
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing ISOLEUCINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: LEUCINE
donislecel drug variants containing LEUCINE
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing LEUCINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: LYSINE HYDROCHLORIDE
donislecel drug variants containing LYSINE HYDROCHLORIDE
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing LYSINE HYDROCHLORIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM SULFATE ANHYDROUS
donislecel drug variants containing MAGNESIUM SULFATE ANHYDROUS
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing MAGNESIUM SULFATE ANHYDROUS
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: METHIONINE
donislecel drug variants containing METHIONINE
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing METHIONINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: NADIDE
donislecel drug variants containing NADIDE
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing NADIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: NADIDE PHOSPHATE MONOSODIUM
donislecel drug variants containing NADIDE PHOSPHATE MONOSODIUM
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing NADIDE PHOSPHATE MONOSODIUM
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: NIACIN
donislecel drug variants containing NIACIN
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing NIACIN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: NIACINAMIDE
donislecel drug variants containing NIACINAMIDE
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing NIACINAMIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: PHENYLALANINE
donislecel drug variants containing PHENYLALANINE
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing PHENYLALANINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
donislecel drug variants containing POLYSORBATE 80
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing POLYSORBATE 80
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM CHLORIDE
donislecel drug variants containing POTASSIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing POTASSIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: PROLINE
donislecel drug variants containing PROLINE
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing PROLINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: PYRIDOXINE HYDROCHLORIDE
donislecel drug variants containing PYRIDOXINE HYDROCHLORIDE
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing PYRIDOXINE HYDROCHLORIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: RIBOFLAVIN
donislecel drug variants containing RIBOFLAVIN
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing RIBOFLAVIN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SERINE
donislecel drug variants containing SERINE
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing SERINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM ACETATE ANHYDROUS
donislecel drug variants containing SODIUM ACETATE ANHYDROUS
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing SODIUM ACETATE ANHYDROUS
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
donislecel drug variants containing SODIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing SODIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM GLUCONATE
donislecel drug variants containing SODIUM GLUCONATE
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing SODIUM GLUCONATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
donislecel drug variants containing SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: THIAMINE HYDROCHLORIDE
donislecel drug variants containing THIAMINE HYDROCHLORIDE
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing THIAMINE HYDROCHLORIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: THREONINE
donislecel drug variants containing THREONINE
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing THREONINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TRISODIUM URIDINE 5'-TRIPHOSPHATE DIHYDRATE
donislecel drug variants containing TRISODIUM URIDINE 5'-TRIPHOSPHATE DIHYDRATE
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing TRISODIUM URIDINE 5'-TRIPHOSPHATE DIHYDRATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TRYPTOPHAN
donislecel drug variants containing TRYPTOPHAN
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing TRYPTOPHAN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TYROSINE DISODIUM DIHYDRATE
donislecel drug variants containing TYROSINE DISODIUM DIHYDRATE
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing TYROSINE DISODIUM DIHYDRATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: VALINE
donislecel drug variants containing VALINE
Company | Ingredient | NDC |
---|---|---|
CellTrans Inc | donislecel | 73539-001 |
>Company | >Ingredient | >NDC |
donislecel drug variants not containing VALINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.